# Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts

> **NCT06162468** · NA · NOT_YET_RECRUITING · sponsor: **University of Auckland, New Zealand** · enrollment: 20 (estimated)

## Conditions studied

- Intraductal Papillary Mucinous Neoplasm of Pancreas

## Interventions

- **PROCEDURE:** Endoscopic ultrasound-guided pancreatic cyst chemoablation (EUS-PCA) using gemcitabine and paclitaxel

## Key facts

- **NCT ID:** NCT06162468
- **Lead sponsor:** University of Auckland, New Zealand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-31
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-07-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-04-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06162468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06162468, "Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06162468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*